NCT05271526View on ClinicalTrials.gov

Real World Evidence of Benralizumab in Eosinophilic Severe AsThma in Russia (BEST)

CompletedOBSERVATIONAL

Enrollment

3

Participants

Timeline

Start Date

May 16, 2022

Primary Completion Date

November 13, 2023

Study Completion Date

November 13, 2023

Conditions

Severe Eosinophilic Asthma

Trial Locations (1)

105077

City clinical hospital No57, Moscow

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY